CN1127570C - Application of castor silkworm cell nucleus and skeleton combination elements - Google Patents

Application of castor silkworm cell nucleus and skeleton combination elements Download PDF

Info

Publication number
CN1127570C
CN1127570C CN98122023A CN98122023A CN1127570C CN 1127570 C CN1127570 C CN 1127570C CN 98122023 A CN98122023 A CN 98122023A CN 98122023 A CN98122023 A CN 98122023A CN 1127570 C CN1127570 C CN 1127570C
Authority
CN
China
Prior art keywords
sar
gene
plu
expression
eukaryotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN98122023A
Other languages
Chinese (zh)
Other versions
CN1223299A (en
Inventor
赵慕钧
吴震宇
何明亮
李载平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institutes for Biological Sciences SIBS of CAS
Original Assignee
Shanghai Institute of Biochemistry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Biochemistry filed Critical Shanghai Institute of Biochemistry
Priority to CN98122023A priority Critical patent/CN1127570C/en
Publication of CN1223299A publication Critical patent/CN1223299A/en
Application granted granted Critical
Publication of CN1127570C publication Critical patent/CN1127570C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to a costor silkworm SAR element in the length of about 1, 000 bp, which can be specifically combined with a cell nucleus skeleton. The SAR element is applied to the construction of a eukaryotic gene expression vendor, specifically the SAR element is inserted into a plasmid pLu to construct a pLu-SAR eukaryotic gene expression vendor which transfects NIH3T3 cells, and thereby, the expression activity ratio comparison of exogenous gene firefly luciferase genes in eukaryotic cells is enhanced by 17 times. The SAR element is a strong enhancer element, is utilized to construct a eukaryotic gene expression vendor and has the advantage of high-efficiency and stable expression of exogenous genes, and furthermore, the SAR element can be further applied to the vendor construction of gene engineering and gene treatment.

Description

The application of castor silkworm cell nucleus and skeleton combination elements
The invention belongs to molecular cytobiology, eukaryotic gene expression control technique research field.Be specifically related to a novel transcriptional enhancer element---the cell nucleus and skeleton combination elements (SAR) of Semen Ricini silkworm rRNA gene, this SAR element application can improve efficient, the stably express of foreign gene in eukaryotic cell in the structure of expression vector.
Eukaryotic nucleus is after removing dissociative DNA, histone and other soluble proteins behind the nuclease digestion, a residual network-like structure is called nuclear skeleton or nuclear matrix.Nuclear skeleton is kept nuclear form, and form three-dimensional space with thousands of genes in the nucleus duplicate, transcribe, process and vital movement such as transportation is organized in certain space.On the chromatin some specific DNA zones can with the nuclear skeleton specific combination, be called nuclear skeleton land (SAR) or nuclear matrix land (MAR).SAR/MAR is usually located at the base portion of chromatin ring, determines chromatinic higher structure, and gene duplicated and transcribed regulating and controlling effect.
External detection and characteristic (the Mirkovitch J thereof that has reported histone gene bunch SAR the earliest by Mirkovitch J etc., et al., Cell, 1984,39:223~232), find that SAR is the dna sequence dna (A+T>70%) that is rich in A, T, be about 400~1000bp, can be specifically and the nuclear skeleton protein binding.Then Cockerill and Garrard reported the immunoglobulin (Ig) kappa gene MAR (Cell, 1986,44:273-282), find that this MAR contains the recognition site of topoisomerase II; Along with the fundamental research to SAR/MAR deepens continuously, the SAR/MAR of increasing gene is detected, the function of SAR/MAR causes people's extensive interest, and Phi-VanL etc. have reported that in 90 years lysozyme of chicken gene 5 ' MAR can strengthen the transcriptional activity of allogeneic promoter.The SAR element of Semen Ricini silkworm rRNA gene cluster has been reported in our laboratory recently, and (1998,28 (1): 42~49), this element is by our clone, order-checking and identify for Zhao Mujun etc., Chinese science (C collects).The present invention is in the structure of expression vector, to improve foreign gene stability and high efficiency expression in eukaryotic cell with this SAR element application.
For this reason, the objective of the invention is the SAR element by the clone Semen Ricini silkworm, the SAR element application at the external eukaryotic gene expression vector of setting up into, is carried the foreign gene transfecting eukaryotic cells by this carrier, the stability and high efficiency that strengthens foreign gene is expressed.
Construction process about Semen Ricini silkworm SAR element clone is by at first detecting and identify the nuclear skeleton land (SAR) of Semen Ricini silkworm rRNA gene, then this SAR is inserted the EcoRI-SacII site of pBluescript (pSK+) plasmid, be built into pSK (+)-SAR and clone (see figure 1).This SAR is about 1, the dna fragmentation of 000bp, behind dna sequence analysis, show, this SAR is rich in A, T base (A+T>70%), contain the topII site and zymic autonomously replicating sequence (ACS) waits other tumor-necrosis factor glycoproteins and structure fancy, the sequence of DNA is formed and is shown that this SAR is an important function element (see figure 2).
It is example that the present invention is set up into eukaryotic gene expression vector pLu-SAR with the SAR element, and structure is seen Fig. 3.This carrier contains SAR and reporter gene luciferin enzyme (Luciferase) gene and some selection markers.This construction of carrier is with EcoRI and SacII double digestion pSK-SAR plasmid (see figure 1), the SAR fragment is separated, mended with the Klenow enzyme then and put down, connect the BamHI joint, insert the BamHI site of pLu plasmid, be built into pLu-SAR expression vector (Fig. 3).The pLu plasmid contains SV40 promotor and luciferin enzyme gene (Luc), contains cyanomycin resistant gene (Amp R) and neomycin resistance gene (Neo R) selection markers.Luciferase gene is the foreign gene that is inserted on the plasmid vector, and it is imported eukaryotic cell, by detecting the vigor of luciferin enzyme, determines the expression of exogenous gene height.Fig. 4 is the detected result of luciferin enzyme activity.With pLu plasmid transfection cells of mamma animals NIH3T3, luciferin enzyme expression of gene is very low, with it in contrast, with pLu-SAR transfection cells of mamma animals NIH3T3, finds that SAR can strengthen about 17 times of the stably express of luciferin enzyme gene in eukaryotic cell.PAGLu as positive control (pAGLu and pLu plasmid are so kind as to give by U.S. Kohwi-Shigematsu T. laboratory), behind the rotaring copolymering NIH 3 T 3 cell, is strengthened seven times of luciferin enzyme gene expressions, similar (Bode J, et al, Science to reported in literature, 1992,255:195~197).Therefore we clone's SAR element application as a kind of enhancer element, improves about 17 times of expression of exogenous gene in carrier for expression of eukaryon, has very high activity.
The invention has the advantages that of the expression of SAR element at the horizontal regulatory gene of chromatin Structure, the carrier for expression of eukaryon pLu-SAR that utilizes the SAR element to make up, foreign gene is imported eukaryotic cell and be incorporated on the karyomit(e), SAR can strengthen the promotor vigor on karyomit(e), and genetic expression is strengthened.Because exogenous origin gene integrator is on karyomit(e), be assigned in offspring's daughter cell with cell fission, be difficult for losing, so the ability of SAR reinforcing gene expression has the advantage of stability and high efficiency, be specially adapted to gene therapy, to improve the expression of therapeutic gene.Because SAR/MAR can be combined on the nuclear skeleton, helps improving the level and the stability thereof of expressing protein, is applicable to eukaryotic cell producer gene engineering product, improves the quality.
The present invention is further elaborated by the following drawings and embodiment, but does not limit the scope of the invention.
Description of drawings:
Fig. 1 is pSK (+)-SAR clone of Semen Ricini silkworm SAR element
Fig. 2 is that the dna sequence dna of Semen Ricini silkworm SAR element is formed
Fig. 3 is the collection of illustrative plates of eukaryotic gene expression vector pLu-SAR
Fig. 4 is the detected result that Semen Ricini silkworm SAR element strengthens the relative vigor of luciferin enzyme
The detection and the clone of embodiment 1 Semen Ricini silkworm SAR element
A. separate and prepare ricinus silk gland tissue nucleus
Get 1~3 day ricinus silk gland tissue, 3~5g in 5 ages, homogenate is also filtered, homogenate buffer is an Al (0.25mol/L sucrose, 10mmol/L Tris-HCl (pH8.0), the 5mmol/L magnesium chloride), 1, centrifugal 10 minutes of 500rpm, collecting precipitation also suspends with Al, adds final concentration and be 0.5% Triton X-100, and ice bath is after 10 minutes, 1, centrifugal 10 minutes of 500rpm with Al suspension precipitation, makes the 2.2mol/L sucrose density gradient ultra-centrifugation, super centrifugal condition is 20,000rpm, 60 minutes, throw out was a nucleus.
B. the preparation of cell nucleus and skeleton
Nucleus through super centrifugation, with diiodosalicylic acid lithium salts (LIS) buffer B (5mmol/L Tris-HCl pH7.4,20mmol/L Repone K, 0.125mmol/L spermidine, 0.05mmol/L spermine, (the import packing of 0.1% digitonin, agent delivery station, Shanghai), 0.1mmol/L PMSF) suspend, then with reference to Mirkovitch (Cell, 1984,39:223~232) method prepares nuclear skeleton, is that 20mmol/L diiodo-salicylic acid lithium salts extracts histone and other soluble proteins in the nuclear with final concentration promptly, with 1,000u/mL restriction enzyme EcoRI and SacII digestion chromatin, centrifugation and nuclear skeleton bonded DNA.
C. the detection of Semen Ricini silkworm SAR element and pSK (+)-SAR clone's structure
Walk 1~1.2% agarose electrophoresis after DNA is purified, 32P-α-dATP (Amersham product) mark rRNA gene fragment is made probe, and 5 ' EcoRI-SacII fragment of results of hybridization proof Semen Ricini silkworm rRNA gene is about 1, and 000bp can combine with nuclear skeleton, is defined as the SAR element of Semen Ricini silkworm.EcoRI-SacII site with this SAR inserts pBluescript (pSK+) is built into pSK (+)-SAR and clones (see figure 1), and the dna sequence dna composition of SAR element is seen Fig. 2.
Embodiment 2 Semen Ricini silkworm SAR element application are in the pLu-SAR Construction of eukaryotic
With SacII and EcoRI double digestion, the SAR fragment is downcut from pSK (+)-SAR plasmid, with the Klenow enzyme mend flat after, connect the BamHI joint, cut out sticky end with BamHI again after, insert the BamHI site of pLu plasmid, be built into pLu-SAR carrier for expression of eukaryon (see figure 3), the pLu plasmid is by U.S. Kohwi-Shigematsu, and the T. laboratory provides, be laboratory plasmid commonly used, the pLu plasmid contains penicillin resistance gene (Amp R) and neomycin resistance gene Neo RAs selection markers, contain the SV40 promotor and, determine that by the vigor of measuring the luciferin enzyme expression of exogenous gene just as the luciferin enzyme reporter gene (Luc) of foreign gene.The vigor of pLu plasmid expression Luc is very low, therefore can be used as contrast.With the BamHI site that Semen Ricini silkworm SAR element inserts the pLu plasmid, be positioned at 5 ' upstream of SV40 promotor, if the expression that this SAR element can enhancing gene, the vigor of luciferin enzyme just improves after testing.
Embodiment 3 Semen Ricini silkworm SAR elements strengthen the detection of foreign gene expression activity in eukaryotic cell
Carrier for expression of eukaryon pLu-SAR with embodiment 2 structures, and pLu in contrast, as each 1.5 μ g of the pAGLu plasmid of positive control, lipofection amine reagent (GIBCO company product) 6 μ l, rotaring copolymering NIH 3 T 3 cell, transfection method is undertaken by the operational manual that company provides, and the NIH3T3 cell count is about 2.5 * 10 5/ 60mm plate screens with 0.7mg/mL G418 after 48 hours in transfection, obtain anti-G418 resistance clone after, the checking plasmid DNA be incorporated on the chromosomal DNA, detect the luciferin enzymic activity then.The authentication method that plasmid DNA is incorporated on the chromosomal DNA is: extract cell genomic dna with ordinary method, with PCR certification mark gene Neo RExistence, the PCR condition is: 94 ℃ 45 seconds, 55 ℃ 45 seconds, 72 1 minute 30 seconds, 30 circulations, 1% agarose electrophoresis is identified, the 790bpDNA amplified fragments occurs, illustrates that plasmid DNA is incorporated on the cell genomic dna.The activity of luciferin enzyme is measured with luciferin enzyme detection system (Promega company product), and method is seen Promega company product description, and LB9507 fluorescence calculating instrument is EG﹠amp; G Berthold company product.Measurement result as shown in Figure 4, the relative intensity of fluorescence reading is respectively: 3T3/pLu is 2033; 3T3/pAGLu is 14028; 3T3/pLu-SAR is 33954.3T3/pAGLu cell relative intensity of fluorescence is bigger seven times than 3T3/pLu cell, similar (Bode J to reported in literature, et al., Science, 1992,255:195~197), its relative intensity of fluorescence of 3T3/pLu-SAR cell has then strengthened 17 times, illustrates that SAR is applied to the ability that eukaryotic expression vector has very strong enhancing exogenous gene expression.

Claims (2)

1. the application of a castor silkworm cell nucleus and skeleton combination elements is characterized in that this element application in making up eukaryotic gene expression vector, strengthens the expression of foreign gene in eukaryotic cell.
2. the application of castor silkworm cell nucleus and skeleton combination elements as claimed in claim 1 is characterized in that described eukaryotic gene expression vector is pLu-SAR, and SAR is positioned at the upstream of SV40 promotor, and wherein, SAR is meant the nuclear skeleton land.
CN98122023A 1998-11-20 1998-11-20 Application of castor silkworm cell nucleus and skeleton combination elements Expired - Fee Related CN1127570C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN98122023A CN1127570C (en) 1998-11-20 1998-11-20 Application of castor silkworm cell nucleus and skeleton combination elements

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN98122023A CN1127570C (en) 1998-11-20 1998-11-20 Application of castor silkworm cell nucleus and skeleton combination elements

Publications (2)

Publication Number Publication Date
CN1223299A CN1223299A (en) 1999-07-21
CN1127570C true CN1127570C (en) 2003-11-12

Family

ID=5227510

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98122023A Expired - Fee Related CN1127570C (en) 1998-11-20 1998-11-20 Application of castor silkworm cell nucleus and skeleton combination elements

Country Status (1)

Country Link
CN (1) CN1127570C (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016650A1 (en) * 1996-10-17 1998-04-23 E.I. Du Pont De Nemours And Company Enhanced transgene expression in a population of monocot cells employing scaffold attachment regions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016650A1 (en) * 1996-10-17 1998-04-23 E.I. Du Pont De Nemours And Company Enhanced transgene expression in a population of monocot cells employing scaffold attachment regions

Also Published As

Publication number Publication date
CN1223299A (en) 1999-07-21

Similar Documents

Publication Publication Date Title
Klämbt The Drosophila gene pointed encodes two ETS-like proteins which are involved in the development of the midline glial cells
Montag-Sallaz et al. Misguided axonal projections, neural cell adhesion molecule 180 mRNA upregulation, and altered behavior in mice deficient for the close homolog of L1
Strambio-de-Castillia et al. Proteins connecting the nuclear pore complex with the nuclear interior
WO2022047876A1 (en) Duchenne muscular dystrophy-related exonic splicing enhancer, sgrna and gene editing tool, and applications
US20100124740A1 (en) Somatic transfer of modified genes to predict drug effects
CA2189975A1 (en) Peptide-mediated gene transfer
Strauss et al. Molecular complementation of a collagen mutation in mammalian cells using yeast artificial chromosomes.
Hardison et al. Comparative analysis of the locus control region of the rabbit β-like globin gene cluster: HS3 increases transient expression of an embryonic ε-globin gene
EP0914326A1 (en) Molecule and method for importing dna into a nucleus
D'Urso et al. Human glucose-6-phosphate dehydrogenase gene carried on a yeast artificial chromosome encodes active enzyme in monkey cells
CN113881701B (en) Positive transfected cell affinity sorting method and kit
CN1127570C (en) Application of castor silkworm cell nucleus and skeleton combination elements
Genovese et al. Detection of mutations in human type I collagen mRNA in osteogenesis imperfecta by indirect RNase protection
Poletto et al. Creating cell lines for mimicking diseases
CN107881200A (en) A kind of rapid screening method applied to model animal zebra fish transgenosis
CN110904114B (en) Application of Gnb2 gene coding sequence and Gnb2 gene coding sequence in constructing mouse model
Peterson Production and analysis of transgenic mice containing yeast artificial chromosomes
Chambers et al. Sequence, initial functional analysis and protein-DNA binding sites of the mouse βB2-crystallin-encoding gene
Fraefel et al. Preparation of herpes simplex virus type 1 (HSV-1)-based amplicon vectors
CN1868546B (en) Model for screening human scavenger receptor CD36 antagonist and its application
CN112921052A (en) In vivo cell proliferation marking and tracing system and application thereof
CN108949756A (en) A kind of construction method and relevant carriers of zebra fish specific heart expression model
Nahon et al. Pro-melanin-concentrating hormone gene (PMCH) is localized on human chromosome 12q and rat chromosome 7
JPS59501533A (en) Use of eukaryotic promoter chains in the production of proteinaceous substances
US20230357792A1 (en) Method of engineering and isolating adeno-associated virus

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: SHANGHAI INST. OF LIFE SCIENCE, CAS

Free format text: FORMER NAME OR ADDRESS: SHANGHAI INST. OF BIOCHEMISTRY, CHINESE ACADEMY OF SCIENCES

CP03 Change of name, title or address

Address after: 200031 No. 320, Yueyang Road, Shanghai

Patentee after: Shanghai Institute of life Sciences, Chinese Academy of Sciences

Address before: 200031 No. 320, Yueyang Road, Shanghai

Patentee before: Shanghai Research Institute of Biochemistry Chinese Academy of Sciences

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20031112

Termination date: 20131120